Description
Glipmevia 50/1000mg Tablets (30’s)
Glipmevia 50/1000mg is a combination oral antidiabetic medication containing Glimepiride 50mg and Metformin Hydrochloride 1000mg. It is designed for effective management of type 2 diabetes mellitus by targeting blood sugar control through two complementary mechanisms.
Key Features:
-
Glimepiride (50mg): A sulfonylurea that stimulates insulin secretion from pancreatic beta cells.
-
Metformin (1000mg): A biguanide that decreases hepatic glucose production and improves insulin sensitivity.
-
Combination therapy enhances glycemic control and reduces blood glucose fluctuations.
-
Helps manage blood sugar levels alongside diet and exercise.
-
Convenient tablet form for once or twice daily dosing.
Indications:
-
Treatment of type 2 diabetes mellitus in adults when diet and exercise alone do not provide adequate glycemic control.
-
Suitable for patients requiring combination therapy of sulfonylurea and metformin.
Dosage & Administration:
-
Usually taken with meals to reduce gastrointestinal discomfort.
-
Dose tailored according to patient response and tolerance.
-
Regular monitoring of blood glucose and renal function is recommended.
Precautions:
-
Not intended for type 1 diabetes or diabetic ketoacidosis.
-
Use with caution in patients with renal or hepatic impairment.
-
Educate patients on recognizing symptoms of hypoglycemia and lactic acidosis.
-
Inform healthcare providers of all concurrent medications to avoid interactions.
Possible Side Effects:
-
Hypoglycemia (low blood sugar)
-
Gastrointestinal issues such as nausea or diarrhea
-
Weight gain
-
Rare allergic reactions
Storage:
-
Store in a cool, dry place below 25°C.
-
Keep out of reach of children.
Reviews
There are no reviews yet.